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DCE–MRIAbstract Introduction: Differentiating a benign from a malignant adnexal mass would provide a
basis for optimal preoperative planning and may also reduce the number of unnecessary laparoto-
mies patients undergoing treatment for benign disease. MRI provides additional information on the
composition of soft-tissue masses using differences in MR relaxation properties seen in various
types of tissue. More recently developed MRI sequences, like diffusion weighted, susceptibility
weighted, and dynamic contrast enhancement sequences provided additional capacities for adnexal
lesion tissue characterization.
Aim of the work: The aim of this work was to study the role of MRI including the novel sequences,
namely dynamic contrast enhanced MRI (DCE–MRI), diffusion weighted images (DWI) and sus-
ceptibility weighted images (SWI) in the characterization of ovarian masses.
Patients and methods: This study included 25 patients having indeterminate adnexal masses at
ultrasound. They were subjected to pelvic MRI, including T1, T2, T1 fat sat sequences, as well
as the DWI, SWI, and DCE sequences. Final diagnosis was reached through histopathological data,
or therapeutic response.
Results: All endometriomas showed blooming on SWI. All malignant lesions showed restricted dif-
fusion and type III DCE curves.
Conclusion: MRI, especially the more recent sequences (DWI, SWI and DCE) allows accurate
characterization of ovarian lesions.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Determining whether a clinically diagnosed adnexal mass is be-
nign or malignant is frequently not possible until surgical
exploration and histologic examination are performed. Conse-
quently, it may not be possible to decide preoperatively
Table 1 Parameters of MR sequences.
Sagittal T2 Axial T2 Coronal T2 Axial T1 Axial T1 fat sat SWI DCE
TR/TE 4510/96 5210/71 4000/94 2470/10 2470/97 49/40 5.5/2.3
Echo train length 13 14 13 13 3 1 1
Slice thickness 3.5 5.5 6 5.5 5.5 2 2.5
Gap 5.4 6 7.2 6 6 – –
Field of view 280 · 280 360 · 360 350 · 350 360 · 360 360 · 360 350 · 400 300 · 400
Number of averages 3 2 2 2 2 1 1
Matrix size 205 · 256 256 · 320 460 · 350 288 · 320 288 · 320 177 · 256 166p · 320
Flip angle 150 150 150 150 150 15 10
Sensitivity encoding factor 2 2 2 2 2 – 2
Table 2 Distribution of patients according to the ﬁnal
imaging diagnosis.
Number of
patients
Percentage
(%)
Ovarian pathology
Endometriomas 9 36
Benign neoplasms
Mucinous cystadenoma 2 8
Ovarian ﬁbroma 2 8
Serous cystadenoma 1 4
Mature cystic teratoma 1 4
Borderline neoplasms
Borderline serous
cystadenocarcinoma
2 8
Borderline mucinous
cystadenocarcinoma
1 4
Malignant neoplasms
Mucinous cystadenocarcinoma 1 4
Krukenberg tumor 1 4
Malignant ovarian neoplasm
of unidentiﬁed nature
1 4
Extraovarian pathology
Pelvic hematoma 1 4
Cervical subserous ﬁbroid 1 4
Broad ligament cyst 1 4
Haematosalpinx 1 4
Total 25 100
Table 3 MRI features in patients presenting with
endometriomas.
MRI features Number of
patients
Percentage
(%)
T1 Hyperintense 9 81.8
Hypointense 2 18.2
T2 Hyperintense 6 54.5
Hypointense (shading) 5 45.5
T1 fat sat Hyperintense (not suppressed) 11 100
SWI Blooming 11 100
DWI Not restricted 6 54.5
Restricted 5 45.5
Total 11 100
Contrast was administered to only two of these patients. Both of
which showed internal content (blood clots versus internal septa-
tions). No enhancement was noted after contrast administration
proving the diagnosis of internal blood clots and hence endome-
triotic cysts of the ovaries.
238 O.Y. Dogheim et al.whether conservative or radical surgery is appropriate. A reli-
able method with which to differentiate a benign from a
malignant adnexal mass would provide a basis for optimal pre-
operative planning and may also reduce the number of unnec-
essary laparotomies patients undergoing treatment for benign
disease (1).
Sonography is the initial imaging study of choice in the
evaluation of women with suspected adnexal masses because
of its widespread availability, relatively low cost, and high
sensitivity in the detection of masses. However, sonography
is limited by its decreased speciﬁcity for the diagnosis of
benignity, which can vary from 60% to 95% and result in
as many as 20% of adnexal masses being classiﬁed as indeter-
minate (2).
CT has been used primarily in patients with ovarian malig-
nancies, either to assess disease extent prior to surgery or as a
substitute for second-look laparotomy. CT has a limited value
in the diagnosis of adnexal masses (3).MRI provides additional information on the composition
of soft-tissue masses using differences in MR relaxation prop-
erties seen in various types of tissue. This information is
invaluable in determining the character of soft-tissue masses.
In the pelvis, MRI has been shown to have a 91–93% overall
accuracy for differentiating benign from malignant adnexal tu-
mors particularly when gadolinium-enhanced techniques are
used (4).
Diffusion-weighted imaging exploits the random motion of
water molecules, because water movement in highly cellular
tissues is restricted, the water molecules within such tissue re-
tain their signal even at high b values (500–1000 s/mm2). This
explains why highly cellular tissues such as tumors appear
persistently bright on diffusion-weighted images, even at high
b values (5). An ovarian adnexal mass with a solid component
that exhibits a low signal on T2-weighted images and a low
signal on b1000 diffusion-weighted images is always benign
(6).
Quantitative dynamic contrast enhanced MRI (DCE–MRI)
provides an accurate method for the prediction of malignancy,
particularly in preoperative indeterminate cases (7). The early
enhancement patterns of ovarian epithelial tumors on DCE–
MR images can help distinguish between benign, borderline,
and invasive epithelial tumors (8).
Susceptibility-weighted MRI is a relatively new MRI tech-
nique that maximizes sensitivity to susceptibility effects and
Fig. 1 27 year-old patient with endometriotic cyst in the left ovary. (a) US shows indeterminate isoechoic lesion. (b) Axial T2 shows a
hyperintense ovarian lesion with hypointense septum. (c) Axial T1 shows a hyperintense lesion. (d) Axial T1 fat sat showed no
suppression. (e) SWI showing blooming. (f) T1 fat sat postcontrast showed no enhancement of the septum so diagnosed as a blood clot. (g)
DWI and (h) ADC map showing no restriction.
Role of novel magnetic resonance imaging sequences 239has exquisite sensitivity to blood products such as hemosiderin
and deoxyhemoglobin. This sequence is more sensitive to thesusceptibility difference between tissues than is conventional
T2*-weighted imaging (9–12). Susceptibility-weighted imaging
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240 O.Y. Dogheim et al.can contribute to the diagnosis of endometrioma by depicting
hemosiderin deposition in the cyst wall (12).
The role of these new sequences is only recently discussed in
the literature, and therefore, we aimed to shed lights on this to-
pic in the current study.b
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.2. Aim of the work
The aim of this work was to study the role of MRI including
the novel sequences, namely dynamic contrast enhanced
MRI (DCE–MRI), diffusion weighted images (DWI) and sus-
ceptibility weighted images (SWI) in the characterization of
ovarian masses.
3. Patients and methods
This study included 25 patients having indeterminate adnexal
masses at ultrasound examination and presented to the
Radiodiagnosis Department, Alexandria Main University
Hospital.
All the studied patients were subjected to the following:
(1) Full history taking.
(2) Thorough clinical examination.
(3) The medical ethics were considered: informed patient’s
consent was obtained, the patient should be aware of
the examination, the economic status of the patient is
considered and the patient has to get beneﬁt from the
examination. The Institutional Review Board approved
the study.
(4) Ultrasound examination was done on a Siemens ·300
ultrasound machine (Erlangen, Germany) including a
convex probe for the abdominopelvic approach
(5.2 MHz) and an endovaginal probe for the transvagi-
nal approach if possible (9.4 MHz).
(5) MRI protocol.
(6) Abdominopelvic CT was revised in 6 of our patients.
(7) The ﬁnal diagnosis of the 25 patients included in the
study was based on biopsy and histopathological veriﬁ-
cation in 14 patients (56%). The other 11 patients were
diagnosed by the characteristic MRI features, and fol-
low up by monitoring clinical response to medical treat-
ment (44%).re
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s The two patients diagnosed to have ovarian torsion
were proved surgically.
 All the patients diagnosed with benign and malignant
ovarian neoplasms were pathologically proven.
 Two of the three patients diagnosed as borderline
ovarian neoplasms were pathologically proven.
 Only three of the patients diagnosed as endometrio-
mas were pathologically proven.
 All patients with extraovarian pathologies were im-
proving on medical treatment.a
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MRI sequences were acquired on an Avanto 1.5T closed mag-
net MRI machine (Siemens, Erlangen, Germany) using
phased-array pelvic coils (8 channels).
Fig. 2 64 year-old patient with left ovarian serous cystadenoma complicated by ovarian torsion. (a) Axial T2 shows a hyperintense cystic
lesion. (b) Axial T1 shows a hypointense lesion with no suspicious features. (c) Axial T1 fat sat shows hemorrhagic ascites in douglas
pouch. (d) SWI shows no blooming in the ovarian lesion and blooming of the hemorrhagic ascites. (e) DWI and (f) ADC showing no
restricted diffusion. (g and h) Coronal T2 W images showing thickening and whirling of the left fallopian tube.
Role of novel magnetic resonance imaging sequences 241The patients were placed in the supine position. The urinary
bladder was in moderate repletion. All sequences wereacquired with saturation bands placed anteriorly and posteri-
orly to eliminate the high signal from subcutaneous fat. The
242 O.Y. Dogheim et al.patients fasted for 3 h and did not receive an antispasmodic
drug before the MRI exam.
Sagittal T2-weighted fast spin-echo sequence from one fem-
oral head to the other, axial T2-weighted fast spin-echo se-
quence from the renal hilum to the symphysis pubis, axial
T1-weighted spin-echo sequence, Coronal T2 weighted fastFig. 3 34 year-old patient with right ovarian mature cystic teratoma.
right ovarian lesion. (c) Axial T1 fat sat shows complete suppression o
showing areas of restricted diffusion.spin-echo sequence (if needed) and susceptibility-weighted
sequence were systematically added. The acquisition protocols,
including sequences and parameters, are given in Table 1.
DWMR images were obtained in the axial plane by using a
single-shot echo-planar sequence with the sensitivity encoding
technique (sensitivity encoding factor, 2). The b valuesAxial T2 (a) and Axial T1 (b) show a heterogeneous hyperintense
f the signal intensity denoting fatty content. (d) DWI and (e) ADC
Role of novel magnetic resonance imaging sequences 243corresponding to the diffusion-sensitizing gradient were 0, 500,
and 1000 s/mm2. All images were acquired with a section
thickness of 5 mm and intersection gaps of 7.5 mm. Motion-
probing gradient pulses were placed in the three orthogonal
planes. Isotropic DW images were generated by using the three
orthogonal axis images.
DCE T1-weighted gradient-echo sequences (two dimen-
sional [2D] fast low-angle shot [FLASH]) were acquired in a
plane allowing to show the solid tissue of the ovarian tumor
(i.e., solid portion, papillary projections, or thickened irregularFig. 4 37 year-old patient with bilateral mucinous cystadenomas. (a)
Axial T2 shows a hyperintense signal with multiple shades in different
shows no blooming. (e) DWI and (f) ADC showing areas of restrictedsepta) and the normal myometrium in a single image. Gadolin-
ium chelate (DOTAREM; Guerbet, Aulnay, France) was gi-
ven at a dose of 0.1 mmol/kg via a power injector at a rate
of 2 mL/s, followed by 20 mL of normal saline to ﬂush the tub-
ing. 12 dynamic sequences were acquired, each having an
acquisition time of 20 s, thus giving a total time of 4 min for
the dynamic sequence, and beginning immediately after the
bolus injection. Postcontrast axial and sagittal T1-weighted
spin-echo sequences with fat saturation were acquired after
gadolinium injection.Axial T1 shows an intermediate signal intensity of the lesion. (b)
loculi (stained glass appearance). (c) Sagittal T2 W image. (d) SWI
diffusion.
244 O.Y. Dogheim et al.3.2. Data analysis
Images were transferred to a post-processing workstation (Syn-
go B15). Regions of interest (ROIs) are placed within solid tis-
sue selected on precontrast MR images and on normal outer
myometrium to measure signal intensity versus time. Normal
myometrium is used as an internal reference tissue. MyometrialFig. 5 61 year-old patient with right sided ﬁbrotic lesion and adenom
ﬁbroid. (a and b) Axial T1 and T2 show a hypointense signal intensity
T1 fat sat postcontrast showing only mild enhancement of the lesion an
the enhancement pattern of the myometrium and the continuous line is
(subserous ﬁbroid will have a type 2 curve, similar enhancement dynatime intensity curve has a sigmoid pattern, which is in the same
signal intensity range than those of ovarian tumors and thus is
useful for tumor characterization. Time-intensity curves (over
all frames) are determined for semi quantitative or pharmaco-
kinetic perfusion analysis. Because tumors are often heteroge-
neous, several ROIs are drawn, and only the maximum
enhancement parameters are taken into account for analysis.yosis. D.D. includes right sided ovarian ﬁbroma versus subserous
of the lesion. (c) DWI showing no areas of restricted diffusion. (d)
d (e) type 1 dynamic enhancement curve. Dotted line representing
that of the lesion. This narrows the D.D to only ovarian ﬁbroma.
mics as the myometrium).
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Role of novel magnetic resonance imaging sequences 2454. Results
The present work included 25 female patients with indetermi-
nate adnexal lesions on ultrasound examination.
The patients included in the study had a ﬁnal imaging diag-
nosis of ovarian lesions in 21 patients (84%) and 4 patients had
extraovarian pathologies (16%) (Table 2).
4.1. MRI diagnosis
Nine patients were diagnosed as ovarian endometriomas, two
had bilateral disease; they showed the following MRI features
(Table 3, Fig. 1).
Six patients were diagnosed as benign ovarian neoplasms,
they showed the following MRI features (Table 4, Figs. 2–5).
Three patients were diagnosed as borderline ovarian neo-
plasms; one of them had bilateral disease. They showed the fol-
lowing MRI features (Table 5, Fig. 6).
Three patients were diagnosed as malignant ovarian neo-
plasms; they showed the following MRI features (Table 6,
Fig. 7).
5. Discussion
5.1. Endometriomas
Since two of the patients had bilateral disease, we increased the
total number of endometriomas in the study to 11 and they
showed the following MRI features:
Nine out of 11 patients showed hyperintense T1 and only 2
showed hypointense signal. Six showed T2 hyperintense signal
and ﬁve showed a hypointense signal.
All 11 patients did not suppress in the T1 fat sat sequence,
which is matching with what Spencer and Weston stated. They
said that the classical MRI features of endometriosis are: (1)
high signal on T1 weighted images (methemoglobin), (2) no
loss of this signal on fat suppressed T1 weighted images and
(3) dark structures on T2 weighted images. These can be rings
or nodules (hemosiderin staining) in chronic lesions or from
deoxyhemoglobin contained within recent bleeding. A key
ﬁnding is ‘‘shading’’ in which there is progressive signal loss
due to T2* effects in the dependent portion of a lesion due
to greater concentrations of blood products. Fluid–ﬂuid levels
may be seen (13).
Woodward et al. stated that hemosiderin-laden macro-
phages combined with the ﬁbrous nature of the cyst wall give
it a low signal intensity appearance on both T1- and T2-
weighted images (14), which explains the 2 cases showing T1
hypointense signal.
All of our 11 cases showed blooming in the SWI sequence.
According to Takeuchi et al. to diagnose endometrioma with
MRI, visualization of hemosiderin deposition in the cyst wall
may be helpful, especially in the diagnosis of endometriomas
that do not exhibit typical MRI ﬁndings. Susceptibility-
weighted MRI is a relatively new MRI technique that maxi-
mizes sensitivity to susceptibility effects and has exquisite sen-
sitivity to blood products such as hemosiderin and
deoxyhemoglobin (11). Woodward et al. stated that the most
problematic lesions to differentiate are hemorrhagic corpus
luteum cysts, whose MR imaging appearance can be similar
246 O.Y. Dogheim et al.to that of endometriomas. Hemorrhagic cysts are usually uni-
locular as opposed to endometriomas, which are frequently
multilocular and bilateral. In addition, hemorrhagic cysts do
not exhibit shading on T2-weighted images and will resolve
with time. A follow-up examination (this can be done with
US) can conﬁrm the diagnosis. Ovarian carcinoma can occa-
sionally have internal hemorrhage. Visualization of solid com-
ponents, septations, and a size larger than expected for an
endometrioma are features suggestive of malignancy (14).
Five out of our 11 cases showed restriction in the DWI se-
quence (could be phase dependent) while the others did not
restrict.
According to Thomassin-Naggara et al. in a study con-
ducted on 124 women, a low b1000 signal intensity within
the solid component was more frequent in benign than in
malignant masses and that the b1000 signal intensity within
the cystic component did not differ signiﬁcantly between
malignant and benign adnexal masses. An ovarian adnexal
mass with a solid component that exhibits a low signal on
T2-weighted images and a low signal on b1000 diffusion-
weighted images is always benign (6). In another study con-
ducted by Feuerlein et al. on 230 patients who underwent
abdominal MRI, including diffusion-weighted imaging had aFig. 6 23 year-old patient with right sided borderline serous cyst
projections. (b) Sagittal postcontrast T1 fat sat sequence showing the en
curve. Dotted lines representing the enhancement pattern of the myomtotal of 55 lesions with restricted diffusion. Only 43 lesions
were malignant and the remaining 12 were benign lesions in
a different abdominal organ, one patient had hemorrhagic
ovarian cyst. They concluded that restricted diffusion is gener-
ally considered to be associated with malignant tumors be-
cause of the high cellularity of these tumors. However, in
interpretation of diffusion-weighted images, it should be kept
in mind that a number of benign lesions could exhibit re-
stricted diffusion on images with high b values, thus mimicking
malignant lesions (15). And in another study conducted by El
sorogy et al. which was performed on 20 patients with ovarian
masses, it was concluded that the direct visual assessment of
DWI of ovarian lesions is not useful in differentiating benign
from malignant ovarian lesions; however, DWI plays a com-
plementary role in detecting the solid components of malig-
nant lesions. Determining the threshold of the ADC for
diagnosing cystic ovarian tumors is difﬁcult because of their
large variance (16).
Contrast was administered in only two of our patients.
Both were not conﬁdently diagnosed before contrast adminis-
tration due to the suspected presence of internal septations
and/or mural nodules. After contrast administration, neither
enhancing internal soft tissue nodules nor septations wereadenocarcinoma. (a) Ultrasound examination showing papillary
hancing papillary projections and (c) type 1 dynamic enhancement
etrium and the continuous line is that of the lesion.
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Role of novel magnetic resonance imaging sequences 247found and hence the diagnosis of internal blood clots was
established.
Woodward et al. also stated that administration of gadolin-
ium-based contrast material is not particularly useful in the
evaluation of endometriomas. When used, the cyst wall dem-
onstrates a nonspeciﬁc, variable enhancement pattern that
does not differentiate it from other benign and malignant pro-
cesses. In addition, a false-positive diagnosis may be made
when normally enhancing parametrium is misinterpreted as
endometriotic foci. The use of gadolinium should be reserved
for those cases in which there is a concern for ovarian carci-
noma (14).
5.2. Benign ovarian neoplasms
 The two mucinous cystadenomas showed complex cystic
nature with stained glass appearance. One of them showed
areas of restricted diffusion (could be attributed to the viscid
contents) while the other did not restrict. Only one of them
was given contrast owing to complex nature with multiple
internal septations and the absence of internal solid compo-
nents could not be conﬁrmed in the precontrast sequences.
 The patient with serous cystadenoma had a simple cystic
lesion. No contrast was administrated.
Jung et al. reported similar criteria as regards the differen-
tiation between these two pathological entities. It was stated
that a tumor that manifests as an unilocular or multilocular
cystic mass with homogeneous CT attenuation or MR imaging
signal intensity of the locules, a thin regular wall or septum,
and no endocystic or exocystic vegetation is considered to be
a benign serous cystadenoma.
And a tumor that manifests as a multilocular cystic mass
that has a thin regular wall and septa or that contains liquids
of different attenuation or signal intensity but has no endocy-
stic or exocystic vegetation is considered to be a benign mucin-
ous cystadenoma and that mucinous cystadenomas tend to be
larger than serous cystadenomas at presentation (16).
 The two patients with ovarian ﬁbroma showed solid soft tis-
sue lesions. Both were administered contrast, and showed
mild enhancement mounting to a type 1 curve.
According to Shinagare et al. ﬁbromas and ﬁbrothecomas,
which are benign ovarian stromal tumors, account for only 4%
of all ovarian neoplasms but represent the most common solid
primary ovarian tumors in asymptomatic women of all ages.
The importance of correct diagnosis of ﬁbromas and ﬁbrothe-
comas lies in their benign nature. These are relatively common
incidental solid ovarian tumors, and the ability to make a diag-
nosis of this benign tumor on imaging can greatly affect the
patient management, especially in terms of avoiding unneces-
sary surgery, decreasing patient anxiety, and avoiding morbid-
ity associated with invasive surgical procedures. It is also
important to differentiate them from broad ligament ﬁbroids
(leiomyomata), because of differences in the management of
these entities (17).
Despite their characteristic MRI features, it can still be dif-
ﬁcult to distinguish ﬁbromas and ﬁbrothecomas from ﬁbroids,
usually pedunculated subserosal or broad ligament ﬁbroids.
Fig. 7 55 year-old patient with bilateral mucinous cystadenocarcinoma. (a) Axial T1 shows bilateral heterogeneous hypointense ovarian
cystic lesions. (b) Axial T2 cuts showing heterogeneous hyperintense lesions with stained glass appearance. Multiple papillary projections
are seen. (c) Coronal T1 fat sat postcontrast showing papillary projections. (d) DWI and (e) ADC showing restricted diffusion. (f)
Abdominal scans reveal thickening of the peritoneal reﬂections and ascites denoting peritoneal carcinomatosis. (g) Type 3 dynamic
enhancement curve. Dotted lines representing the enhancement pattern of the lesion and the continuous line is that of the myometrium.
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Role of novel magnetic resonance imaging sequences 249Dynamic contrast-enhanced MRI has been reported to aid in
this distinction where the enhancement of ﬁbromas and ﬁbro-
thecomas was signiﬁcantly lower than that for myometrium
and ﬁbroids at all time points (17) which agrees with our ﬁnd-
ings where the ovarian ﬁbromas always showed a type 1 curve
in PW sequence and a type 2 curve was noted in the case with
cervical subserous ﬁbroid although both of them showed sim-
ilar morphological features making it impossible to suspect
their origins without PWI.
 The last patient had mature cystic teratoma and showed
heterogeneous hyperintense T1 and T2 signal that sup-
pressed in the fat sat sequence. No contrast was
administrated.
Similar ﬁndings were stated by Park et al. who stated that
the diagnosis of uncomplicated teratomas at MR imaging is
fairly straightforward because it is very sensitive for detection
of intratumoral fat. Intratumoral fat can be diagnosed with the
combination of T1-weighted imaging and fat-saturated T1-
weighted imaging; intratumoral fat shows high signal intensity
on T1-weighted images but signal drop on fat-saturated T1-
weighted images. Chemical-selective fat-saturated T1-weighted
imaging is mandatory for diagnosis of teratomas because other
conditions, such as hemorrhage or a high concentration of
protein, can also cause T1 shortening (18).
Two out of the six patients, one of the ovarian ﬁbroma pa-
tients and the patient with serous cystadenoma, were compli-
cated by ipsilateral ovarian torsion. Both showed thickening
of the ipsilateral fallopian tube, ipsilateral edematous and en-
larged ovary and associated ascites, which were hemorrhagic in
the patient with ﬁbroma.
According to Chang et al. the most constant ﬁnding in
ovarian torsion is a large ovary. Common ﬁndings that are
somewhat nonspeciﬁc include an adnexal mass that may be
in the midline or rotated toward the contralateral side of the
pelvis, deviation of the uterus to the side of the affected ovary,
engorged blood vessels on the twisted side, pelvic ascites, and
obliteration of fat planes. In cases of hemorrhagic infarct, a
few characteristic ﬁndings can be seen, including a beaked pro-
trusion at the periphery of the affected ovary – a ﬁnding con-
sistent with engorged blood vessels – hematoma, and the
absence of enhancement (19).
Thomassin-Naggara et al. stated that the following criteria
were considered predictive of benignity: purely cystic lesions, a
regular and homogeneous solid component with low signal
intensity at T2-weighted imaging, a solid component without
high signal intensity on DW images obtained at b= 1000 s/
mm2, and a solid component with a type 1 time-signal intensity
curve on PW images (20).
In the current study, the diagnosis of a benign lesion was
based on the same MR criteria.
5.3. Borderline ovarian neoplasms
 The two patients with borderline serous cystadenocarcino-
mas showed cystic nature with thick enhancing wall and
multiple enhancing papillary projections seen after contrast
administration. One of the lesions showed a type 2 curve
while the other a type 1 curve. Doppler examination was done to the patient with type 1
curve and showed evident blood ﬂow within the papillary
projections.
 The patient with borderline mucinous cystadenocarcinoma
had a complex cystic lesion with stained glass appearance
and thick enhancing septations seen after contrast adminis-
tration that showed a type 2 curve.
Thomassin-Naggara et al. stated that only invasive tumors
displayed time intensity curve type 3 (speciﬁcity 100%).
Enhancement curve types 1 and 2 corresponded to benign
and borderline ovarian tumors, respectively, however, with a
signiﬁcant overlap (21).
In a study conducted on 283 women with adnexal masses,
Hassen et al. stated that the association of morphologic and
vascular ultrasound ﬁndings could highly suggest the diagnosis
of benign or malignant papillary projection. It was concluded
that for papillary projectionsP10 mm, color ﬂow was present
in all malignant, in 86% of borderline, and absent in all benign
tumors (22).
Bouic-Pages et al. stated that the presence of vegetations or
papillary excrescences suggests the diagnosis of borderline epi-
thelial tumor and that their number and size are proportion-
ally related to the tumor aggressiveness (23).
5.4. Malignant ovarian neoplasms
 The patient with mucinous cystadenocarcinoma had a com-
plex cystic lesion with stained glass appearance. DWI
showed restricted diffusion with ADC value of 0.9. Thick
enhancing wall and enhancing papillary projections were
seen after contrast administration that showed a type 3
curve.
 This patient had associated peritoneal carcinomatosis and
lung deposits.
 The patient with Krukenberg tumor had a solid mass lesion
that showed restricted diffusion with ADC value of 0.8.
Strong heterogeneous enhancement was seen after contrast
administration mounting to a type 3 curve.
This patient had history of gastric carcinoma and right
oophorectomy for Krukenberg tumor.
 The last patient had advanced malignant ovarian tumor
whose nature could not be further identiﬁed. Restricted dif-
fusion was seen with ADC value of 0.7. and strong hetero-
geneous enhancement after contrast administration
mounting to a type 3 curve.
This patient had associated ascites and omental nodules.
According to Thomassin-Naggara et al., the following cri-
teria were considered predictive of malignancy: vegetations,
an irregular or heterogeneous solid component with intermedi-
ate signal intensity at T2-weighted imaging, a solid component
with high signal intensity on DW images obtained at a b value
of 1000 s/mm2, a solid component with a type 3 time-signal
intensity curve on PW images, or associated abdominal or pel-
vic ascites or peritoneal implants (20).
To sum up, the special MRI sequences used in our study
were useful in characterization of ovarian lesions as follows:
250 O.Y. Dogheim et al.(A) Susceptibility weighted imaging (SWI):
In our study, SWI sequence was done in all of our patients
suffering from ovarian pathology and has proved effective in
diagnosis of endometrioma. All of our endometrioma patients
had evident blooming in the SWI sequence and all the rest did
not bloom. Hence SWI was effective in diagnosis of 100% of
the cases of endometriomas.
(B) Dynamic contrast-enhanced magnetic resonance
imaging:
DCE sequence was done in 11 of our patients: two endome-
trioma patients, three of the patients suffering from benign
ovarian pathology, three patients with borderline and three
with malignant ovarian neoplasms.
It has proved effective in all of the patients were:
 No enhancement was seen in the endometrioma
patients.
 The benign category showed:
o Enhancement of the thin walls and septations in the
mucinous cystadenoma patient.
o Mild enhancement mounting to a type 1 curve in both
ovarian ﬁbroma patients.
 The borderline category showed:
o Type 2 curve in two of the patients; one of the patients
with borderline serous and the patient with mucinous
cystadenocarcinoma.
o A type 1 curve in the other patient with borderline ser-
ous cystadenocarcinoma, which was diagnosed as bor-
derline owing to the presence of papillary projections
with internal blood ﬂow (seen by Doppler
examination).
 The malignant category showed:
o Intense enhancement with a type 3 curve in all three
patients.
Hence DCE sequence is effective in differentiating
between benign and malignant lesions, however overlap be-
tween the benign and borderline categories may occur which
should be differentiated by their different morphologic
criteria.
(C) Diffusion weighted sequence DWI:
In our study, DWI sequence was done in all of our patients
suffering from ovarian pathology. The following was
observed:
 Restriction was noted in ﬁve out of the 11-endometri-
oma patients.
 In the benign category: areas of restricted diffusion
were seen in two out of the six patients; one mucinous
cystadenoma and the mature cystic teratoma patient.
 In the borderline category: no restriction was seen in
any of the three patients. In the malignant category: all three patients showed
restricted diffusion with ADC values of 0.7, 0.8 and
0.9.
In neuroradiology, it is known that according to the stage
of the hematoma, DWI is variable where the hematoma is seen
restricted in the hyperacute and late subacute stages only while
it is not restricted in the other stages (24).
The presence of restriction in some of our endometrioma
cases could be attributed to the same principle. However the
different morphological changes according to the age of the
hematoma are not yet evaluated in gynecological imaging.
Hence, restricted diffusion is seen in all malignant lesions,
however some benign lesions may also show restricted diffu-
sion. Given that DWI ﬁndings are not considered in isolation,
information derived from images obtained with other se-
quences should greatly reduce the diagnostic dilemma.
However, an ovarian adnexal mass with a solid component
that exhibits a low signal on T2-weighted images and a low sig-
nal on b1000 diffusion-weighted images is always benign.
Themain limitation of the study is the small number of cases,
which did not allow further detailed statistical analysis. This was
due to the time limitations, as well as the slow acceptance by the
gynecology colleagues to the utility of our technique.
Therefore, now that these sequences have acquired wider
acceptance among our clinical colleagues, we plan to study
these sequences on a larger scale and using extensive statistical
analyses.
6. Conclusions
 Sonographically indeterminate adnexal masses of
uncertain origin and solid or complex cystic content
beneﬁt from further evaluation with MRI, which is
highly accurate for identifying the origin of a mass
and characterizing its tissue content, obviating surgery
in many cases.
 Susceptibility-weighted imaging contributes to the
diagnosis of endometrioma by depicting hemosiderin
deposition in the cyst wall.
 DCE MR imaging is useful in distinguishing malignant
from benign tumors, and for characterizing gyneco-
logic masses. It also helps to distinguish ovarian ﬁbro-
mas from uterine leiomyomas.
 Enhancement curve types 1 and 2 corresponded to
benign and borderline ovarian tumors, respectively,
however, with a signiﬁcant overlap. Enhancement
curve type 3 always corresponded to malignant ovarian
tumors.
 An ovarian lesion with no restricted diffusion is always
a benign lesion. All malignant ovarian lesions are
always restricted in the DWI with ADC values less
than 1. An ovarian lesion with restricted diffusion
could also be benign, so information derived from
images obtained with other sequences are helpful.
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